These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15262735)

  • 1. Clustering of Parkinson disease: shared cause or coincidence?
    Kumar A; Calne SM; Schulzer M; Mak E; Wszolek Z; Van Netten C; Tsui JK; Stoessl AJ; Calne DB
    Arch Neurol; 2004 Jul; 61(7):1057-60. PubMed ID: 15262735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy.
    Malaspina A; Alimonti D; Poloni TE; Ceroni M
    Funct Neurol; 2002; 17(4):177-82. PubMed ID: 12675260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the use of clusters to determine environmental influence on disease.
    Hutchinson M; Lebedev S
    Arch Neurol; 2005 Feb; 62(2):331; author reply 331-2. PubMed ID: 15710868
    [No Abstract]   [Full Text] [Related]  

  • 4. Family-based case-control study of cigarette smoking and Parkinson disease.
    Scott WK; Zhang F; Stajich JM; Scott BL; Stacy MA; Vance JM
    Neurology; 2005 Feb; 64(3):442-7. PubMed ID: 15699372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of Parkinson's disease genetics.
    Lorincz MT
    Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
    Brouwers N; Nuytemans K; van der Zee J; Gijselinck I; Engelborghs S; Theuns J; Kumar-Singh S; Pickut BA; Pals P; Dermaut B; Bogaerts V; De Pooter T; Serneels S; Van den Broeck M; Cuijt I; Mattheijssens M; Peeters K; Sciot R; Martin JJ; Cras P; Santens P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; Sleegers K
    Arch Neurol; 2007 Oct; 64(10):1436-46. PubMed ID: 17923627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin variability has no major role in Parkinson disease genetic etiology.
    Nuytemans K; Pals P; Sleegers K; Engelborghs S; Corsmit E; Peeters K; Pickut B; Mattheijssens M; Cras P; De Deyn PP; Theuns J; Van Broeckhoven C
    Neurology; 2008 Oct; 71(15):1147-51. PubMed ID: 18838661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-environment interactions in Parkinson's disease.
    Ross CA; Smith WW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder.
    Klein C; Schlossmacher MG
    Neurology; 2007 Nov; 69(22):2093-104. PubMed ID: 17761553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease and genetics.
    Lester J; Otero-Siliceo E
    Neurologist; 2006 Sep; 12(5):240-4. PubMed ID: 16990735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?
    Verbaan D; Boesveldt S; van Rooden SM; Visser M; Marinus J; Macedo MG; Fang Y; Heutink P; Berendse HW; van Hilten JJ
    Neurology; 2008 Dec; 71(23):1877-82. PubMed ID: 19047559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
    Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
    Charles P; Camuzat A; Benammar N; Sellal F; Destée A; Bonnet AM; Lesage S; Le Ber I; Stevanin G; Dürr A; Brice A;
    Neurology; 2007 Nov; 69(21):1970-5. PubMed ID: 17568014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation.
    Battisti C; Formichi P; Radi E; Federico A
    J Neurol Sci; 2008 Apr; 267(1-2):120-4. PubMed ID: 18061619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of Parkinson's disease points to environmental etiology.
    Goldsmith JR; Herishanu Y; Abarbanel JM; Weinbaum Z
    Arch Environ Health; 1990; 45(2):88-94. PubMed ID: 2334236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease. Coincidence or connection?
    Stone R
    Science; 2002 Apr; 296(5567):451-2. PubMed ID: 11964452
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinson's disease. Genetic analysis and evidence of a multifactorial etiology.
    Kondo K; Kurland LT; Schull WJ
    Mayo Clin Proc; 1973 Jul; 48(7):465-75. PubMed ID: 4716218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parkinson disease and environmental factors].
    Zayed J; Campanella G; Panisset JC; Ducic S; Andre P; Masson H; Roy M
    Rev Epidemiol Sante Publique; 1990; 38(2):159-60. PubMed ID: 2374846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.